The Lancet Gastroenterology & Hepatology in conversation with
Un pódcast de The Lancet Group
88 Episodo
-
Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease
Publicado: 12/7/2023 -
Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis
Publicado: 7/6/2023 -
Adelina Artenie on the incidence of HIV and HCV in people who inject drugs
Publicado: 10/5/2023 -
Johan Burisch on the costs of inflammatory bowel disease in high-income settings
Publicado: 12/4/2023 -
Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease
Publicado: 8/2/2023 -
Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer
Publicado: 23/1/2023 -
Dan Turner on vedolizumab in children with IBD
Publicado: 6/1/2023 -
Simon Baunwall on faecal microbiota transplantation for first or second Clostridioides difficile infection
Publicado: 9/11/2022 -
James Alexander on immune responses to COVID-19 vaccination in patients with IBD
Publicado: 5/10/2022 -
Filip Knop on liraglutide for bile acid diarrhoea
Publicado: 7/9/2022 -
Edward Kim on radiation segmentectomy for unresectable very early to early stage hepatocellular carcinoma
Publicado: 4/8/2022 -
Joep Ijspeert on serrated polyp detection and risk of interval post-colonoscopy colorectal cancer
Publicado: 6/7/2022 -
Elise Meima-van Praag on surgical closure for Crohn’s disease perianal fistulas
Publicado: 14/6/2022 -
Juan Pablo Arab on NAFLD public health policies in the Americas
Publicado: 9/5/2022 -
Sarah Blach on hepatitis C virus epidemiology
Publicado: 6/4/2022 -
Sunil Solomon on a minimal monitoring approach for hepatitis C virus infection
Publicado: 23/3/2022 -
Rupert Leong on oral faecal microbiota transplantation in ulcerative colitis
Publicado: 9/3/2022 -
Swati Patel on early-onset colorectal cancer
Publicado: 9/2/2022 -
Emilie Breekveldt on FIT-based screening for colorectal cancer in the Netherlands
Publicado: 10/12/2021 -
Wendy Spearman on non-alcoholic fatty liver disease in sub-Saharan Africa
Publicado: 11/11/2021
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
